These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2087691)

  • 41. Etiopathophysiology of disseminated intravascular coagulation.
    Bakhshi S; Arya LS
    J Assoc Physicians India; 2003 Aug; 51():796-800. PubMed ID: 14651143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Plasma interleukin-6 in patients with disseminated intravascular coagulation].
    Minamikawa K; Wada H; Ohiwa M; Kaneko T; Tsukada T; Kageyama S; Kobayashi T; Tomeoku M; Katou M; Minami N
    Rinsho Ketsueki; 1992 Dec; 33(12):1797-801. PubMed ID: 1479690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation.
    Müller-Berghaus G; Reuter C; Bleyl U
    Am J Pathol; 1976 Feb; 82(2):393-406. PubMed ID: 1251892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
    Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
    Yun-Choi HS; Pyo MK; Chang KC; Lee DH
    Planta Med; 2002 Apr; 68(4):326-9. PubMed ID: 11988856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Significance of heparin in the treatment of patients with sepsis].
    Sun Q; Chen E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Dec; 29(12):1144-1147. PubMed ID: 29216953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
    Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
    Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation.
    Kumon K; Tanaka K; Nakajima N; Naito Y; Fujita T
    Crit Care Med; 1984 Dec; 12(12):1039-43. PubMed ID: 6439471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microvascular coagulopathy and disseminated intravascular coagulation.
    ten Cate H; Schoenmakers SH; Franco R; Timmerman JJ; Groot AP; Spek CA; Reitsma PH
    Crit Care Med; 2001 Jul; 29(7 Suppl):S95-7; discussion S97-8. PubMed ID: 11445741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of heparin on fibrinogen formation during experimental toxic syndrome of disseminated intravascular coagulation].
    Barkagan ZS; Momot AP; Glazunova GA; Taranina TS; Koltakova SI
    Ukr Biokhim Zh (1978); 1988; 60(1):23-9. PubMed ID: 3363673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The role of multiple organ failure in DIC].
    Shiba T
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):873-7. PubMed ID: 6676659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difference between sepsis and trauma diagnosed as sensitive diagnostic criteria for disseminated intravascular coagulation.
    Wada H; Hatada T
    Thromb Haemost; 2008 Dec; 100(6):958-9. PubMed ID: 19132215
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical aspects of DIC--disseminated intravascular coagulation.
    Matsuda T
    Pol J Pharmacol; 1996; 48(1):73-5. PubMed ID: 9112631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
    Marbet GA; Griffith MJ
    Thromb Haemost; 1986 Feb; 55(1):78-85. PubMed ID: 3518133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of antibiotic treatment with the thrombin inhibitor recombinant hirudin for the therapy of experimental Klebsiella pneumoniae sepsis.
    Dickneite G; Czech J
    Thromb Haemost; 1994 Jun; 71(6):768-72. PubMed ID: 7974345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Progress in diagnosis and treatment for disseminated intravascular coagulation].
    Wada H; Matsumoto T; Aota T; Yamashita Y
    Rinsho Ketsueki; 2015 Feb; 56(2):169-76. PubMed ID: 25765797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.